CYTOMX THERAPEUTICS INC (CTMX)

US23284F1057 - Common Stock

4.43  -0.07 (-1.56%)

After market: 4.69 +0.26 (+5.87%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
101.21M53.20M37.30M100.40M57.50M
Operating Expenses
107.70M146.80M153.40M149.00M168.40M
Research and Development
77.68M106.30M114.20M112.90M131.60M
Selling, General, and Administrative Expenses
30.02M40.40M39.20M36.00M36.80M
Operating Income
-6.48M-93.60M-116.00M-48.60M-110.90M
Interest Income/Expense
9.84M1.70M300.00K1.80M8.40M
Other Income/Expense
-30.00K300.00K-100.00K0.00-100.00K
Non Recurring Items
N/A-7.70MN/AN/AN/A
Income Before Taxes
3.32M-99.30M-115.90M-46.80M-102.70M
Income Tax
3.89M0.000.00-13.90M-400.00K
Net Income
-569.00K-99.30M-115.90M-32.90M-102.20M
EBITDA
-4.31M-91.20M-113.30M-46.10M-108.30M
 
Per Share Data
EPS Diluted Total Ops
-0.01-1.51-1.81-0.71-2.26
Non GAAP EPS
-0.02-1.52-1.31-0.72-2.25
 
Statistics
Profit Margin
-0.56%-186.65%-310.72%-32.77%-177.74%
Operating Profit Margin
-6.41%-175.94%-310.99%-48.41%-192.87%

All data in USD

Charts